Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection
IFR Journal of Medicine and Surgery · 18.07.2025 · 2 (3) · 13-20
DOI: 10.70146/msv02i03.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift IFR Journal of Medicine and Surgery, erschienen am 18.07.2025. Verfasst von Manav Devalraju Sai Rajesh und 5 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is a major global health burden associated with significant cardiovascular and renal complications. Traditionally, diabetes management focused primarily on glycaemic control; however, recent advances have shifted the therapeutic goals toward comprehensive cardiovascular and renal protection.
Objective
This review aims to explore the evolving trends in T2DM management, highlighting therapies that extend beyond glucose lowering to address broader cardiovascular and renal outcomes.
Methods
A comprehensive analysis of key cardiovascular outcomes trials (CVOTs) and updated guideline recommendations was performed, with emphasis on the clinical application of novel antihyperglycemic agents.
Results
Sodium-glucose co-transporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists have demonstrated significant reductions in major adverse cardiovascular events, hospitalization for heart failure, and progression of chronic kidney disease. Integration of cardiovascular risk management including blood pressure control, lipid management, and antiplatelet therapy has become a critical component of modern diabetes care. Despite these advances, challenges such as therapeutic inertia, access disparities, and the need for personalized treatment approaches persist. Emerging therapies, including dual incretin receptor agonists and precision medicine strategies, offer promising avenues for future care.
Conclusion
Contemporary management of T2DM requires a holistic, multidisciplinary approach that addresses the complex interplay between metabolic, cardiovascular, and renal health. Continued innovation and equitable implementation of evidence-based therapies are essential to improve long-term outcomes for patients with diabetes.
Zitieren
APA
Rajesh, M. D. S., Gomaa, A. R. M., Soliman, L. A. F. A., Albakir, W., Subair, J., & Mohyeddin, A. (2025). Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection. IFR Journal of Medicine and Surgery, 2(3), 13-20. https://doi.org/10.70146/msv02i03.003
Vancouver
Rajesh MDS, Gomaa ARM, Soliman LAFA, Albakir W, Subair J, Mohyeddin A. Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection. IFR Journal of Medicine and Surgery. 2025;2(3):13-20. doi:10.70146/msv02i03.003
BibTeX
@article{Rajesh2025,
author = {Rajesh, Manav Devalraju Sai and Gomaa, Ahmed Roshdi Mohamed and Soliman, Lina Akmal Fouad Abdelhamid and Albakir, Walid and Subair, Jassim and Mohyeddin, Ali},
title = {Novel Trends in the Management of Type 2 Diabetes: Beyond Glycaemic Control to Cardiovascular Protection},
journal = {IFR Journal of Medicine and Surgery},
year = {2025},
volume = {2},
number = {3},
pages = {13--20},
doi = {10.70146/msv02i03.003}
}
EUVIMED